Identifying tick species that spread Crimean-Congo Hemorrhagic Fever virus
Official title: Morphological and molecular identification of Hyalomma tick vectors of Crimean-Congo Hemorrhagic Fever virus
Funded at Georgia Southern University · NIH-11220492 · Data updated 2026-11-12
This study is all about figuring out which types of ticks can spread the Crimean-Congo Hemorrhagic Fever virus, so we can find better ways to identify them and help keep everyone safe from tick-borne illnesses.
Quick facts
| Grant type | R15 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgia Southern University NIH-funded |
| Lab location | 1 site (Statesboro, United States) |
| Project start | June 1, 2025 |
| Project end | May 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $355,000 |
| NIH project number | 1R15AI188251-01A1 |
| Project ID | NIH-11220492 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals living in or traveling to regions where Hyalomma ticks are prevalent and at risk of CCHF.
✕Less likely to help
Patients who do not reside in or travel to areas affected by Hyalomma ticks or CCHF may not benefit from this research.
What this research studies
This research focuses on understanding and identifying specific tick species, particularly those in the Hyalomma genus, that are responsible for transmitting the Crimean-Congo Hemorrhagic Fever (CCHF) virus. The project aims to develop both morphological and molecular tools to accurately identify these ticks, especially in their immature stages, which are often difficult to distinguish. By improving identification methods, the research seeks to enhance surveillance and prevention strategies for tick-borne diseases, ultimately contributing to better public health outcomes.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention and treatment strategies for diseases caused by tick-borne pathogens, including CCHF.
How similar studies have gone: Previous research has shown success in identifying tick species using molecular techniques, indicating that this approach has potential for effective outcomes.
Where this research is happening
-
Georgia Southern University
Statesboro, United States Active
Researchers
- Principal investigator: Apanaskevich, Dmitry a — Georgia Southern University
- Study coordinator: Apanaskevich, Dmitry a
Related research
Other NIH-funded projects on the same topics.
-
Broad antiviral drugs that target coronaviruses and other viruses
A research program aims to identify small molecules that can block multiple viruses, focusing first on coronaviruses, to help create drugs that can treat future outbreaks.
-
Finding broadly protective antibodies against Crimean-Congo Hemorrhagic Fever
Researchers will study blood from people who survived CCHF to find human antibodies that protect against multiple virus variants, with early tests in animal models to check their breadth.
-
Antivirals for hemorrhagic fever viruses like LASV, SFTSV, and EBOV
A multi-institutional effort to find and validate antiviral compounds that block key viral proteins from LASV, SFTSV, and EBOV to help people at risk from serious hemorrhagic fevers.
-
A New Model for Valley Fever: Studying Coccidioides Infection with Volatile Clues in Wax Moths
Researchers are testing a new, cheaper model using wax moths to study Valley Fever caused by Coccidioides, with the goal of understanding how the infection behaves and how it could be diagnosed or treated.
-
Halogen-modified nucleoside analogs to fight yellow fever virus
Aims to develop new oral medicines that could prevent or treat yellow fever by using specially modified building blocks that stop the virus from growing.
-
Understanding Guanarito virus and building countermeasures for Venezuelan hemorrhagic fever
This project studies how Guanarito virus causes disease and aims to develop vaccines or treatments to protect people in areas where Venezuelan hemorrhagic fever occurs.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.